RTTNews | Jul 20, 2020 08:50AM EDT

08:50 Monday, July 20, 2020 (RTTNews.com) - Cumberland Pharmaceuticals Inc. (CPIX) said that a single-center, randomized, double-blind, placebo-controlled study results demonstrated that Caldolor Injection significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture.

In addition, the time to first narcotic medication was longer in the Caldolor group than with hospital standard of care. Further, pain was managed better in the Caldolor group compared to standard of care narcotics.

In Monday pre-market trade, CPIX is currently trading at $4.36 up $1.07 or 32.52 percent.

Read the original article on RTTNews ( https://www.rttnews.com/3112361/cumberland-pharma-caldolor-shows-reduction-of-opioid-use-in-orthopedic-trauma-patients.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved